Role of mechanical stress in mitigating chemotherapy-associated bone loss
Role of mechanical stress in mitigating chemotherapy-associated bone loss
批准号:
10722845
负责人:
JULIA THOM OXFORD
金额:
$28.03万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
未结题
起止时间:
2014-08-01 至 2025-05-31
关键词:
Administrative SupplementAgeBiologyBreast Cancer TreatmentBreast Cancer survivorCancer PatientCancer SurvivorCell Culture TechniquesCell Differentiation processCell SurvivalCellsCenters of Research ExcellenceCisplatinCollagen Type ICore FacilityDNA AdductionDNA AdductsDNA DamageDNA RepairDataData ScienceDepositionDoseEnvironmentExtracellular MatrixFoundationsFractureGene ExpressionGoalsHairHomeostasisIdahoInstitutionInterventionKineticsLaboratoriesLeadMalignant NeoplasmsMechanical StressMechanicsMesenchymal Stem CellsNauseaNeoplasm MetastasisNucleotide Excision RepairOsteoblastsOsteolysisOsteopeniaOsteoporosisOutcomePatientsPharmaceutical PreparationsPhysical activityPlatinumPopulationPostdoctoral FellowProductionProteinsProteomicsProtocols documentationPublic HealthQualifyingQuality of lifeRecurrenceRecurrent Malignant NeoplasmResearchResearch PersonnelResourcesRiskRoleTestingTherapeutic InterventionToxic effectUniversitiesUp-RegulationWomanWomen&aposs HealthWorkadductanticancer treatmentbonebone healthbone losscancer cellcancer recurrencechemotherapeutic agentchemotherapycompliance behaviordesigneffective therapyexperienceexperimental studyfracture riskimprovedimproved outcomelong-term sequelaemalignant breast neoplasmmechanical forcemortalityosteoblast differentiationosteogenicpluripotencypreventpreventive interventionrepairedresponserural countiessenescenceside effecttargeted treatmenttranscriptome sequencingvibration
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
The Center of Biomedical Research Excellence in Matrix Biology administrative supplement will
support women’s health research in an IDeA state, specifically Idaho. The results of this study
will enhance our understanding of how bone health may be maintained for breast cancer
survivors and those who have undergone chemotherapy. This question is at the foundation of
concerns for women who have had breast cancer treatment and who are therefore at an
increased risk for osteoporosis and fracture. The risk of developing breast cancer increases with
age and is particularly high in women age 60 and older. Because of their age, these women are
already at an increased risk for osteoporosis. Case rates in Idaho are higher than the national
average, and much higher for some of the more rural counties within Idaho. Prevention and
therapeutic interventions are needed to minimize bone loss and reduce fracture risk in this large
and growing population. The proposed work will leverage resources available at Boise State
University, specifically the Biomolecular Research Core and the RNA sequencing laboratory.
The objective for this project is to investigate low-intensity vibration-induced improvements in
both DNA damage repair in mesenchymal stem cells, osteoblast differentiation, and
extracellular matrix production during cisplatin treatment. Results from this project will yield a
greater understanding of how external mechanical force is involved in maintaining bone health
during anti-cancer treatment. At the completion of the proposed experiments, we anticipate a
greater understanding of non-pharmacologic and targeted therapeutic interventions to decrease
long-term sequelae following chemotherapy. The results of the proposed work may reduce bone
fractures, cancer metastasis, and recurrence. Additionally, this administrative supplement will
expand the research and research capacity to conduct women’s health research in the state of
Idaho.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Center of Biomedical Research
-
批准号:8625918
-
项目类别:
-
资助金额:$199.65万
-
财政年份:2014
-
负责人:JULIA THOM OXFORD
-
依托单位:
Center of Biomedical Research
-
批准号:9310452
-
项目类别:
-
资助金额:$198.4万
-
财政年份:2014
-
负责人:JULIA THOM OXFORD
-
依托单位:
Center of Biomedical Research Excellence in Matrix Biology Phase II
-
批准号:10415171
-
项目类别:
-
资助金额:$210.75万
-
财政年份:2014
-
负责人:JULIA THOM OXFORD
-
依托单位:
Center of Biomedical Research Excellence in Matrix Biology Phase II
-
批准号:10640905
-
项目类别:
-
资助金额:$210.75万
-
财政年份:2014
-
负责人:JULIA THOM OXFORD
-
依托单位:
Administrative Core
-
批准号:10640906
-
项目类别:
-
资助金额:$90.0万
-
财政年份:2014
-
负责人:JULIA THOM OXFORD
-
依托单位:
Center of Biomedical Research Excellence in Matrix Biology Phase II
-
批准号:10844074
-
项目类别:
-
资助金额:$72.34万
-
财政年份:2014
-
负责人:JULIA THOM OXFORD
-
依托单位:
Administrative Core
-
批准号:10894421
-
项目类别:
-
资助金额:$72.34万
-
财政年份:2014
-
负责人:JULIA THOM OXFORD
-
依托单位:
Center of Biomedical Research Excellence in Matrix Biology Phase II
-
批准号:10397810
-
项目类别:
-
资助金额:$22.17万
-
财政年份:2014
-
负责人:JULIA THOM OXFORD
-
依托单位:
Administrative Core
-
批准号:8653269
-
项目类别:
-
资助金额:$54.9万
-
财政年份:2014
-
负责人:JULIA THOM OXFORD
-
依托单位:
Administrative Core
-
批准号:10226308
-
项目类别:
-
资助金额:$83.53万
-
财政年份:2014
-
负责人:JULIA THOM OXFORD
-
依托单位:
Administrative Core
-
批准号:10415172
-
项目类别:
-
资助金额:$78.31万
-
财政年份:2014
-
负责人:JULIA THOM OXFORD
-
依托单位:
SARS-CoV-2 Surveillance Studies in Southwest Idaho
-
批准号:10594358
-
项目类别:
-
资助金额:$70.1万
-
财政年份:2014
-
负责人:JULIA THOM OXFORD
-
依托单位:
Center of Biomedical Research
-
批准号:8898140
-
项目类别:
-
资助金额:$203.95万
-
财政年份:2014
-
负责人:JULIA THOM OXFORD
-
依托单位:
Center of Biomedical Research Excellence in Matrix Biology Phase II
-
批准号:10226307
-
项目类别:
-
资助金额:$210.75万
-
财政年份:2014
-
负责人:JULIA THOM OXFORD
-
依托单位:
MULTIPLICITY OF COL11A1 FUNCTION DURING DEVELOPMENT; STRUCTURE AND SIGNALING
-
批准号:8359680
-
项目类别:
-
资助金额:$11.15万
-
财政年份:2011
-
负责人:JULIA THOM OXFORD
-
依托单位:
MULTIPLICITY OF COL11A1 FUNCTION DURING DEVELOPMENT; STRUCTURE AND SIGNALING
-
批准号:8167434
-
项目类别:
-
资助金额:$11.27万
-
财政年份:2010
-
负责人:JULIA THOM OXFORD
-
依托单位:
SKELETAL BIOLOGY AND ARTHRITIS
-
批准号:7959941
-
项目类别:
-
资助金额:$10.28万
-
财政年份:2009
-
负责人:JULIA THOM OXFORD
-
依托单位:
SKELETAL BIOLOGY AND ARTHRITIS
-
批准号:7720026
-
项目类别:
-
资助金额:$6.66万
-
财政年份:2008
-
负责人:JULIA THOM OXFORD
-
依托单位:
Type XI collagen isoforms in skeletal biology
-
批准号:6462827
-
项目类别:
-
资助金额:$7.09万
-
财政年份:2002
-
负责人:JULIA THOM OXFORD
-
依托单位:
Type XI collagen isoforms in skeletal biology
-
批准号:7100220
-
项目类别:
-
资助金额:$7.98万
-
财政年份:2002
-
负责人:JULIA THOM OXFORD
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: